A detailed history of Franklin, Parlapiano, Turner & Welch, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Franklin, Parlapiano, Turner & Welch, LLC holds 2,118 shares of ABT stock, worth $243,061. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,118
Previous 2,118 -0.0%
Holding current value
$243,061
Previous $220,000 9.55%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 21, 2023

BUY
$100.78 - $112.29 $213,452 - $237,830
2,118 New
2,118 $230,000
Q4 2022

Jan 31, 2023

BUY
$95.06 - $111.52 $182,325 - $213,895
1,918 New
1,918 $210,000
Q2 2021

Jul 30, 2021

SELL
$105.79 - $124.53 $105 - $124
-1 Reduced 0.05%
1,918 $222,000
Q3 2020

Oct 30, 2020

BUY
$91.64 - $111.29 $175,857 - $213,565
1,919 New
1,919 $209,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Franklin, Parlapiano, Turner & Welch, LLC Portfolio

Follow Franklin, Parlapiano, Turner & Welch, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin, Parlapiano, Turner & Welch, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Franklin, Parlapiano, Turner & Welch, LLC with notifications on news.